A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity

Biological Psychiatry

Volumn 47, Issue 7, 2000, Pages 643-649

  Heinz, Andreas ^a   Jones, Douglas W ^a   Mazzanti, Chiara ^b   Goldman, David ^b   Ragan, Paul ^b   Hommer, Dan ^b   Linnoila, Markku ^b   Weinberger, Daniel R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

CIT; Alcoholism; Gene expression; Serotonin transporters; SLC6A4; SPECT

Indexed keywords

3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; ALCOHOL; IODINE 123; SEROTONIN TRANSPORTER;

ADULT; ALCOHOL CONSUMPTION; ALCOHOLISM; ALLELE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE EXPRESSION; GENOTYPE; HOMOZYGOSITY; HUMAN; MALE; NEUROTOXICITY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAPHE NUCLEUS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; ALCOHOL-INDUCED DISORDERS, NERVOUS SYSTEM; ALCOHOLISM; ALLELES; CARRIER PROTEINS; CASE-CONTROL STUDIES; COCAINE; ETHANOL; GENE EXPRESSION; GENOTYPE; HUMANS; IODINE RADIOISOTOPES; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; POLYMERASE CHAIN REACTION; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TEMPERANCE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0034176712     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(99)00171-7     Document Type: Article

References (39)

1. American Psychiatric Association (1987): Diagnostic and Statistical Manual of Mental Disorders (3rd ed rev). Washington, DC: American Psychiatric Press.
2. Baldwin R., Zea-Ponce Y., Zoghbi S., Laruelle M., Al-Tikriti M., Smith E., et al. Evaluation of the monoamine uptake site ligand [123-I]methyl 3β-(Iodophenyl)-tropane-2β-carboxylate ([123-I]β-CIT) in non-human primates pharmacokinetics, biodistribution and SPECT brain imaging coregistered with MRI . Nucl Med Biol. 5:1993;597-606.
3. Baumgarten HG, Grozdanovic Z (1995): Psychopharmacology of central serotonergic systems. Pharmacopsychiatry (Berl) 28:73-79.
4. Bengel D., Murphy D.L., Andrews A.M., Wichems C.H., Feltner D., Heils A., et al. Altered brain serotonin homeostasis and locomotion insensitivity to 3,4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice. Mol Pharmacol. 53:1998;649-655.
5. Edenberg H.J., Reynolds J., Koller D.L., Begleiter H., Bucholz K.K., Conneally P.M., et al. A family-based analysis of whether the functional promoter alleles of the serotonin transporter gene HTT affect the risk for alcohol dependence. Alc Clin Exp Res. 22:1998;1080-1085.
6. Farde L., Halldin C., Mueller L., Suhara T., Karlsson P., Hall H. PET study of [C-11]β-CIT binding to monoamine transporters in the monkey and human brain. Synapse. 16:1994;93-103.
7. Fils-Aime M.L., Eckhardt M.J., George D.T., Brown G.L., Mefford I., Linnoila M. Early-onset alcoholics have lower cerebrospinal fluid 5-hydroxyindolacetic acid levels than late-onset alcoholics. Arch Gen Psychiatry. 53:1996;211-216.
8. Fisher R.E., Morris E.D., Alpert N.M., Fischman A.J. In vivo imaging of neuromodulatory synaptic transmission using PET a review of relevant neurophysiology . Human Brain Map. 3:1995;24-34.
9. 11C]cocaine binding to decreases in synaptic dopamine. Synapse. 20:1995;137-144.
10. Gelernter J., Kranzler H., Cubells J.F. Serotonin transporter protein (SCL6A4) allele and haplotype frequencies and linkage disequilibria in African- and European-American populations and alcohol-dependent subjects. Hum Genetics. 101:1997;243-264.
11. Goldman D. Why mice drink. Nature Genetics. 13:1996;137-138.
12. Hartka E., Johnstone B., Leino E.V., Motoyoshi M., Temple M.T., Fillmore K.M. The collaborative alcohol-related longitudinal project a meta-analysis of depressive symptomatology and alcohol consumption over time . Br J Addict. 86:1991;1283-1298.
13. Heils A., Teufel A., Petri S., Stöber G., Riederer P., Bengel D., et al. Allelic variation of human serotonin transporter gene expression. J Neurochem. 6:1996;2621-2624.
14. Heinz A., Dufeu P., Kuhn S., Dettling M., Graf K.J., Kurten I., et al. Psychopathological and behavioral correlates of dopaminergic sensitivity in alcohol-dependent patients. Arch Gen Psychiatry. 53:1996;1123-1128.
15. Heinz A., Higley J.D., Gorey J.G., Saunders R.C., Jones D.W., Hommer D., et al. In vivo association between alcohol intoxication, aggression and serotonin transporter availability in non-human primates. Am J Psychiatry. 155:1998;1023-1028.
16. Heinz A., Ragan P., Jones D.W., Hommer D., Williams W., Knable M.B., et al. Reduced serotonin transporters in alcoholism. Am J Psychiatry. 155:1998;1544-1549.
17. Jagust W.J., Eberling J.L., Biegon A., Taylor S.E., van Brocklin H.F., Jordan S., et al. Iodine-123-5-iodo-6-nitroquipazine SPECT radiotracer to image the serotonin transporter . J Nucl Med. 37:1996;1207-1214.
18. Jones D.W., Heinz A., Gorey J.G., Lee K.S., Knable M.B., Urbina R.A., et al. A simple, sensitive and efficient method of directly determining plasma concentrations of free [I-123]β-CIT at extended times by TLC of ultrafiltrates. J Nucl Med. 38:(suppl):1997;287P.
19. Jones DW, Gorey JG, Zajicek K, Das S, Urbina RA, Lee KS, et al (1998): Depletion-restoration studies reveal the impact of endogenous dopamine and serotonin on [I-123]β-CIT SPECT imaging in primate brain. J Nucl Med 39(suppl):42P.
20. Kuikka J.T., Tiihonen J., Bergstrom K.A., Karhu J., Hartikainen P., Viinamaki H., et al. Imaging of dopamine and serotonin transporters in the living human brain. Eur J Nucl Med. 22:1995;346-350.
21. Laruelle M., Baldwin R., Malison R., Zea-Ponce Y., Zoghbi S., Al-Tikriti M., et al. SPECT imaging of dopamine and serotonin transporters with [123-I]β-CIT Pharmacological characterization of brain uptake in non-human primates . Synapse. 13:1993;295-309.
22. Laruelle M., Wallace A., Seibyl J.P., Baldwin M., Zea-Ponce Y., Zoghbi S.S., et al. Graphical, kinetic, and equilibrium analyses of in vivo [123-I]β-CIT binding to dopamine transporters in healthy human subjects. J Cereb Blood Flow Metab. 14:1994;982-994.
23. LeMarquand D., Pihl R.O., Benkelfat C. Serotonin and alcohol intake, abuse, and dependence clinical evidence . Biol Psychiatry. 36:1994;326-337.
24. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 274:1996;1527-1531.
25. Little K.Y., McLaughlin D.P., Zhang L., Livermore C.S., McFinton P.R., DelProposto Z.S., et al. Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels. Am J Psychiatry. 155:1998;207-213.
26. 123I]-2β-carboxy-3β-(4-iodophenyl)tropane and single photon emission computed tomography. Biol Psychiatry. 44:1998;1090-1098.
27. Oglivie A.D., Battersby S., Bubb V.J., Fink G., Harmar A.J., Goodwin G.M., et al. Polymorphism in serotonin transporter gene associated with susceptibility to major depression. Lancet. 347:1996;731-733.
28. Pirker W., Asenbaum S., Kasper S., Walter H., Angelberger P., Koch G., et al. β-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo. J Neural Transm. 100:1995;247-256.
29. Rattray M., Baldessari S., Gobbi M., Mennini T., Samanin R., Bendotti C. p-Chlorphenylalanine changes serotonin transporter mRNA levels and expression of the gene product. J Neurochem. 67:1996;463-472.
30. Rossetti Z.L., Melis F., Carboni S., Diana M., Gessa G.L. Alcohol withdrawal in rats is associated with a marked decrease in extraneural dopamine. Alc Clin Exp Res. 16:1992;529-532.
31. Schuckit M.A., Smith T.L. An 8-year follow-up of 450 sons of alcoholics and control subjects. Arch Gen Psychiatry. 45:1996;211-216.
32. α6 receptors and the serotonin transporter in the level of response to alcohol a pilot study . Biol Psychiatry. 45:1999;647-651.
33. Seibyl J.P., Wallace E., Smith E.O., Stabin M., Baldwin R.M., Zoghbi S., et al. Whole-body biodistribution, radiation absorbed dose and brain SPECT imaging with Iodine-123-β-CIT in healthy human subjects. J Nucl Med. 35:1994;764-770.
34. Selzer M.L. The Michigan Alcoholism Screening Test The quest for a new diagnostic instrument . Am J Psychiatry. 127:1971;1653-1658.
35. Slotkin T.A., McCook E.C., Ritchie J.C., Caroll B.J., Seidler F.J. Serotonin transporter expression in rat brain regions and blood platelets aging and glucocorticoid effects . Biol Psychiatry. 41:1997;172-183.
36. Spitzer R., Williams J., Gibbon M., First M. Structured Clinical Interview for DSM-III-R-Patient Edition (with Psychotic Screen) (SCID I, version 1.0). 1990;American Psychiatric Press, Washington, DC.
37. Spitzer R.L., Williams J.B.W., Gibbon M., First M.B. Structured Clinical Interview for DSM-III-R - Personality Disorders (SCID II, version 1.0). 1990;American Psychiatric Press, Washington, DC.
38. 125I]RTI-55 in vitro binding and autoradiographic characterization . J Neurochem. 62:1994;549-556.
39. Yu A., Yang J., Pawlyk A.C., Tejani-Butt S.M. Acute depletion of serotonin down-regulates serotonin-transporter mRNA in raphe neurons. Brain Res. 688:1995;209-212.